US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 23, 2024 (2 years ago)

minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

What was recalled

minolira (minocycline hydrochloride) extended-release tablets, 105mg 30-count Bottle, Rx Only, Mfg by: Dr Reddy's Laboratories Limited, INDIA, Manufactured for: EPI Health, LLC, Charleston, SC 29403, NDC 71403-101-30.

Recalling firm
EPI Health, LLC
NDC code
71403-101-30
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0474-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all